Update on recognition and management of patients with acquired or inherited hypercoagulability.

Article

Update on recognition and management of patients with acquired or inherited hypercoagulability.

Comprehensive therapy - 1 Jan 2000

Alving B

Abstract excerpt

As many as 20% of individuals who develop venous thromboembolism (VTE) in an outpatient setting may have a mutation in factor V (factor V Leiden) or the prothrombin gene. Through testing for the inherited and acquired conditions for VTE, the clinician can develop strategies to prevent recurrences.

Topics

Antiphospholipid Syndrome
Blood Coagulation Disorders
Factor V
Female
Humans
Male
Mutation
Prothrombin
Thrombophlebitis
Thrombosis

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.